We are live on ! Find out more
PCYC

PHARMACYCLICS INC
PCYC

Delisted

PCYC was delisted on the 22nd of May, 2015.

224 hedge funds and large institutions have $6.59B invested in PHARMACYCLICS INC in 2013 Q3 according to their latest regulatory filings, with 55 funds opening new positions, 67 increasing their positions, 87 reducing their positions, and 30 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding in top 10

Funds holding in top 10: 48 (+4)

83% more first-time investments, than exits

New positions opened: 55 | Existing positions closed: 30

70% more capital invested

Capital invested by funds: $3.88B → $6.59B (+$2.72B)

11% more funds holding

Funds holding: 201224 (+23)

23% less repeat investments, than reductions

Existing positions increased: 67 | Existing positions reduced: 87

35% less call options, than puts

Call options by funds: $138M | Put options by funds: $211M

Holders
224
Holders Change
+23
Holders Change %
+11.44%
% of All Funds
7.26%
Holding in Top 10
8
Holding in Top 10 Change
+4
Holding in Top 10 Change %
+100%
% of All Funds
0.26%
New
55
Increased
67
Reduced
87
Closed
30
Calls
$138M
Puts
$211M
Net Calls
-$73.4M
Net Calls Change
-$35.3M
Name Holding Trade Value Shares
Change
Change in
Stake
BBA
1
Baker Bros. Advisors
New York
$1.25B -$195M -1,760,927 -16%
T. Rowe Price Associates
2
T. Rowe Price Associates
Maryland
$1.14B +$112M +1,011,415 +14%
Vanguard Group
3
Vanguard Group
Pennsylvania
$444M +$1.34M +12,034 +0.4%
Capital World Investors
4
Capital World Investors
California
$432M -$48.3M -435,622 -12%
Fidelity Investments
5
Fidelity Investments
Massachusetts
$396M +$179M +1,610,867 +129%
Primecap Management
6
Primecap Management
California
$329M -$6.55M -59,000 -2%
BIT
7
BlackRock Institutional Trust
California
$191M +$5.19M +46,809 +4%
CCI
8
Columbus Circle Investors
$141M -$19.4M -174,921 -15%
State Street
9
State Street
Massachusetts
$120M -$3.1M -27,945 -3%
Ameriprise
10
Ameriprise
Minnesota
$84M +$30.8M +277,773 +84%
Norges Bank
11
Norges Bank
Norway
$83.8M +$38.1M +343,082 +131%
FAM
12
Fred Alger Management
New York
$80.9M +$48M +432,305 +283%
Goldman Sachs
13
Goldman Sachs
New York
$79.3M -$8.98M -80,932 -12%
Bank of New York Mellon
14
Bank of New York Mellon
New York
$74.2M -$400K -3,604 -0.7%
JHIU
15
Janus Henderson Investors US
Colorado
$74.2M +$2.11M +19,019 +4%
AllianceBernstein
16
AllianceBernstein
Tennessee
$70.1M -$1.52M -13,697 -3%
Franklin Resources
17
Franklin Resources
California
$65.1M -$31.7M -285,540 -38%
Alkeon Capital Management
18
Alkeon Capital Management
New York
$60.8M +$32.2M +290,000 +193%
BFA
19
BlackRock Fund Advisors
California
$58.8M +$4.28M +38,613 +10%
SCA
20
SAC Capital Advisors
Connecticut
$55.6M -$10.7M -96,179 -19%
Lord, Abbett & Co
21
Lord, Abbett & Co
New Jersey
$55.4M +$3.39M +30,550 +8%
BB
22
BB Biotech
Switzerland
$55.2M +$44.3M +399,030 New
QF
23
QVT Financial
New York
$47.6M -$19.5M -175,661 -34%
Northern Trust
24
Northern Trust
Illinois
$43.1M -$39.2M -353,090 -53%
Geode Capital Management
25
Geode Capital Management
Massachusetts
$42.7M +$7.18M +64,708 +27%

PCYC Hedge Fund Activity: Q3 2013 in Review

224 of the 3,084 institutional investors tracked by Wall St. Rank reported a position in PHARMACYCLICS INC (PCYC) for Q3 2013, worth a combined $6.59B — up 70% from $3.88B a quarter earlier.

Buyers outnumbered sellers: 55 funds opened new PCYC positions and 30 closed out — a net gain of 25 holders — while 67 added to existing stakes and 87 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $179M. The largest seller was Baker Bros. Advisors, cutting an estimated $195M.

  • 224 institutional investors held PHARMACYCLICS INC (PCYC) as of Q3 2013, up from 201 in Q2 2013.
  • Funds reported $6.59B of PHARMACYCLICS INC stock for Q3 2013, up 70% quarter-over-quarter.
  • 55 funds opened new PHARMACYCLICS INC positions in Q3 2013 and 30 closed out, a net change of +25 holders.
  • The largest PHARMACYCLICS INC buyer in Q3 2013 was Fidelity Investments, an estimated $179M added.
  • The largest PHARMACYCLICS INC seller in Q3 2013 was Baker Bros. Advisors, an estimated $195M sold.

Based on aggregated 13F filings for Q3 2013.